Episodes

  • Episode 358: Noticias del Dia 1 de Uromigos Live 2024 en Nashville

    Episode 358: Noticias del Dia 1 de Uromigos Live 2024 en Nashville
    Sep 30 2024

    En este podcast cubrimos los temas de cáncer urotelial discutidos por los Uromigos. El impacto del estudio NIAGARA en utiliar quimio más inmunoterapia en neadyuvancia de Ca urotelial músculo invasor, el uso de pembrolizumab adyuvante después de los datos del estudio AMBASSADOR y la búsqueda de biomarcadores.
    Show more Show less
    22 mins
  • Episode 357: #UromigosLive24 - Peri-operative Therapy in Bladder Cancer

    Episode 357: #UromigosLive24 - Peri-operative Therapy in Bladder Cancer
    Sep 30 2024

    Tom leads a panel of Shilpa Gupta, Andrea Apolo and Petros Grivas to discuss and debate this timely topic.
    Show more Show less
    1 hr and 3 mins
  • Episode 356: #UromigosLive24 - Front-line Therapy in Papillary and Non-clear Cell RCC

    Episode 356: #UromigosLive24 - Front-line Therapy in Papillary and Non-clear Cell RCC
    Sep 28 2024

    Brain moderates the panel that discusses and debates TKI, vs Ipi/Nivo vs IO/TKI
    Show more Show less
    26 mins
  • Episode 355: #UromigosLive 24 - Radioligands in prostate cancer

    Episode 355: #UromigosLive 24 - Radioligands in prostate cancer
    Sep 28 2024

    The Uromigos Live 2024 panel discusses recent radioligand data including PEACE-3
    Show more Show less
    54 mins
  • Episode 354: #UromigosLive 24 - T cell directed therapy in prostate cancer

    Episode 354: #UromigosLive 24 - T cell directed therapy in prostate cancer
    Sep 28 2024

    Brian hosts a panel at Uromigos Live 2024 in Nashville with Michael Morris, Tanya Dorff and Karen Autio
    Show more Show less
    44 mins
  • Episode 353: #UromigosLive24 ADC session

    Episode 353: #UromigosLive24 ADC session
    Sep 28 2024

    Tom moderates a live panel of Kala Sridhar, Shilpa Gupta, Andrea Apolo and Petros Grivas on the emerging ADC data in bladder cancer
    Show more Show less
    53 mins
  • Episode 352: ESMO 2024 - RCC and Bladder review

    Episode 352: ESMO 2024 - RCC and Bladder review
    Sep 23 2024

    Tom and Brian finish discussing ESMO 2024 highlights. Even without a guest Tom still interrupts a lot.
    Show more Show less
    26 mins
  • Episode 351: ESMO 2024 review part 1: prostate cancer

    Episode 351: ESMO 2024 review part 1: prostate cancer
    Sep 21 2024

    Silke joins us to discuss ESMO 2024 highlights, then the birds start singing....
    Show more Show less
    19 mins